Therapeutic peptides are gaining attention for their roles in managing various health conditions, and cagrilintide is at the forefront of this revolution
Phase-II wound studies have investigated pressure ulcers, venous ulcers and wounds in epidermolysis bullosa, largely using topical formulations.[8] A 2025 randomised, double-blind study involving 96 patients following ST-elevation myocardial infarction evaluated recombinant human thymosin 4
GHK-Cu topical products are commonly discussed in concentration ranges from 2% to 10%
Persistently raised B12 requires repeat testing, medication review, full blood count, and liver and renal function assessment
The Cas9/sgRNA ribonucleoprotein complex, while the most responsive mode of action, has a low off-target rate and low toxicity, but the large size of the complex complicates delivery